Acasti Pharma (TSXV: APO) Opportunity Knocks 2011

Views 10

Acasti Pharma is developing safe and effective pharmaceutical and medical applications with an initial focus on cardiovascular disease by leveraging the intellectual property, clinical data and know how developed by Neptune Technologies.

Share This Video


Download

  
Report form